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By S. Gronthos, S.E. Graves, S. Ohta, and P.J. Simmons 
The monoclonal  antibody STRO-1 identifies clonogenic  bone 
marrow stromal cell progenitors (fibroblast colony-forming 
units [CFU-F]) in adult human bone marrow. These  STRO- 
l+  CFU-F have previously been shown to give rise to  cells 
with  the  phenotype of fibroblasts, adipocytes, and smooth 
muscle  cells.  In this study, the osteogenic potential of CFU- 
F derived from  the STRO-l+  fraction of adult human bone 
marrow was determined. CFU-F were isolated from normal 
bone marrow aspirates by fluorescence activated cell sort- 
ing,  based on their expression of the STRO-1 antigen. Os- 
teogenic differentiation was assessed by the induction of 
alkaline  phosphatase  expression,  by  the  formation of a min- 
eralized matrix (hydroxyapatite), and by  the production of 
the bone-specific protein osteocalcin. STRO-l+ cells were 
cultured in  the  presence of dexamethasone  (DEX;  mol/ 
L),  ascorbic acid  2-phosphate  (ASC-2P;  100 pmol/L), and in- 
organic phosphate (PO,,;  2.9  mmol/L). After 2  weeks of cul- 
ture,  greater  than 90%  of  the cells in each  CFU-F  colony 
N  VIVO,  HEMATOPOIETIC cells develop in  intimate 
contiguity with a phenotypically and probably function- 
ally diverse population of  mesenchymal, connective tissue 
type cells that, collectively, represent the stromal tissue of 
the bone  marrow (BM).'.* A considerable body of evidence 
derived from studies in  vivo and  in  vitro  shows that  the 
hematopoietic microenvironment (HM) of the hematopoietic 
organs is mediated in large part by this heterogeneous popu- 
lation  of  stromal cells  that  endow these  organs with  the 
unique capacity to support hematopoietic cell development.' 
Cell types comprising the stromal tissue of the BM include 
vascular  endothelial  cells,  smooth  muscle  cells,  reticular 
cells, adipocytes, and  osteoblast^.^" This diversity of stromal 
elements has complicated attempts to elucidate the role of 
each cellular component in the  support of  hematopoiesis. 
Moreover, the  origin  and  developmental relationship be- 
tween each component of  the marrow stroma remains to  be 
determined. Studies in rodents and  in  humans clearly show 
that  marrow stromal tissue is capable of  extensive regenera- 
tion after a variety of  insults ranging from radiation to me- 
chanical di~ruption.~"~  These data raise the question as to 
whether each of the various stromal cell types has prolifera- 
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stained positive for  alkaline  phosphatase  using a  mono- 
clonal antibody specific for bone and liver alkaline  phospha- 
tase. Alkaline phosphatase  activity was confirmed by histo- 
chemistry.  A  mineralized matrix developed in the CFU-F 
cultures,  after  4 weeks of  culture in the presence of DEX, 
ASC-2P.  and PO,,.  Mineralization was confirmed by  both 
light and electron microscopy. The mineral was identified 
as hydroxyapatite  by  electron dispersive  x-ray  microanalysis 
and by x-ray diffraction analysis. In replicate  cultures, osteo- 
calcin  release  was  shown after exposure  of  the cells to  1.25- 
dihydroxyvitamin DJ (10"  mol/L) both by radioimmunoas- 
say  and Northern blot analysis.  This  work provides direct 
evidence that adult human bone marrow-derived CFU-F  are 
capable of  differentiating into functional osteoblasts  and 
that osteoprogenitors are present in  the STRO-l+ popula- 
tion. 
0  1994 by The  American  Society of Hematology. 
tive potential and therefore represent self-maintaining popu- 
lations within the BM. Alternatively, does there exist a popu- 
lation of  stromal cell precursors with the capacity to give 
rise to each of the aforementioned stromal elements and is 
thus responsible for the turnover of  marrow stromal tissue 
under steady-state and perturbed situations? 
Putative stromal cell precursors have been  identified  in  a 
number of species, including humans, by their ability to form 
colonies  of  cells  morphologically  resembling  fibroblasts 
when single-cell suspensions of  BM  mononuclear cells are 
explanted at appropriate densities in liquid culture."-"  The 
clonogenic progenitor responsible for colony formation un- 
der these conditions is referred to as fibroblast colony-form- 
ing unit (CFU-F)."  After their initial description by  Frie- 
denstein,I4 subsequent studies of  the Cm-F population in 
the murine system showed heterogeneous developmental po- 
tentials after ectopic transplantation of  individual CFU-F 
colonies. A minor proportion of  CFU-F were found to de- 
velop into marrow organs containing the  full spectrum of 
stromal cell types, including bone cells, whereas the remain- 
der of  colonies generated stromal organs comprising only 
bone cells or soft connective tissue.I4  Based  on these and 
other data, OwenT5  proposed the stromal stem cell hypothesis 
in which, by  analogy  with  the hematopoietic system, there 
exists a hierarchy of cellular differentiation supported at its 
apex  by  a small compartment of  self-renewing, multipoten- 
tial stromal stem cells. 
Although formal proof of  the existence of  stromal stem 
cells is lacking, this hypothesis has nevertheless provided a 
useful conceptual basis from which  to investigate the devel- 
opmental potential of  marrow stromal tissue. The work of 
Frieden~teinl~  was the first to show the osteogenic potential 
in the mouse. Subsequent in  vitro studies have shown the 
presence of cells with the phenotype of  bone cells in both 
rat and mouse BM cultures when cultured under conditions 
permissive for osteogenic development (L-ascorbate, dexa- 
methasone, and P-glycer~l-phosphate).'~-'~  More recently, a 
cloned murine cell line from the marrow stroma was estab- 
lished that displays osteogenic characteristics, providing di- 
rect evidence that a single stromal progenitor can differenti- 
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ate  into osteoblast-like cells."  In human studies, the ectopic 
transplantation  of  BM cells in diffusion chambers in nude 
mice  has failed to  provide  evidence  of the existence of cells 
with  osteogenic  potential in normal  adult  human  marrow?',zz 
However,  the  formation  of bone  and  cartilage  in diffusion 
chambers  containing marrow from  young  children has been 
re~orted.2~  More  recently,  cultured  adult  human BM cells 
placed  into  ceramic  cubes have  been  shown  to  form bone 
(but  not  cartilage)  when  implanted  in  nude  mi~e.2~  Thus far, 
the use of  in vivo  assays to measure the osteogenic potential 
of  human marrow  cells is clearly  still  at a developmental 
stage. Other  studies  have  examined the osteogenic  potential 
of cultured  human  BM stromal  cells  by  the in  vitro  induction 
and  detection of characteristic  bone  cell  markers,  including 
collagen  type  1 synthesis,  alkaline  phosphatase  expression, 
osteocalcin production, and  bone  mineral  fonnati~n.~~'~~  Col- 
lectively, these studies  show  the presence of cells  with  an 
osteoblast-like  phenotype in human BM cultures. However, 
given  the  heterogeneity  of  the  stromal  cell  population  in 
whole BM, the  question  arises  as  to  whether  these  cells  are 
already  committed  bone  cells  and  whether  the  osteogenic 
phenotype  can  be  induced  in  a more  primitive  stromal  cell 
precursor  population. 
In the present study, we examine the possibility of estab- 
lishing a reproducible  and defined in  vitro  culture  system  to 
directly  show  the  osteogenic  potential  of  Cm-F isolated 
from  adult  human  BM. To avoid the culture of whole BM 
that could  contain  cells already committed  to the osteogenic 
lineage,  human  BM Cm-F  were purified using  the  mouse 
monoclonal antibody  (MoAb) STRO- 1  .31 BM mononuclear 
cells sorted on the  basis  of STRO-1 expression are capable 
of establishing an adherent  stromal  layer  in  vitro, consisting 
of  a number of  phenotypically  distinct  stromal  cell  types, 
including fibroblasts, smooth  muscle  cells,  and  adipo~ytes.~' 
We  show  here  that  in  all  BM samples  examined, the MoAb 
STRO- 1 identifies cells with osteogenic potential as  assessed 
by  the  development  of cells  that  exhibit  three  independent 
markers of  differentiated  bone  cells:  alkaline  phosphatase 
expression; 1,25-dihydroxyvitamin  D,-dependent  induction 
of  the  bone-specific  protein,  osteocalcin;  and  production  of 
a mineralized  matrix  (hydroxyapatite). 
MATERIALS AND  METHODS 
Subjects.  Fresh BM  aspirates  were  obtained  (after  obtaining  in- 
formed  consent)  from  the  iliac  crest  and/or  the  sternum  of  normal 
adult  volunteers,  according  to  procedures  approved  by  the  ethics 
committee  at  the Royal  Adelaide  Hospital.  BM  mononuclear  cells 
(BMMNCs)  were  obtained  by  centrifugation  over  Ficoll  (1.077  g/ 
mL, Lymphoprep;  Nycomed,  Oslo, Norway)  at  400g  for  30 minutes. 
The  BMMNCs  were  washed  twice  in  Hanks'  Buffered  Saline  Solu- 
tion  (HBSS)  supplemented  with  5% fetal calf  serum  (FCS;  batch 
593;  GIBCO  BRL,  Victoria,  Australia)  and  10 mmoVL  HEPES, 
pH  7.35  (GIBCO-BRL)  (HHF),  before  immunolabeling  and  flow 
cytometry. 
Bone  chips  from  the  tibia  were  obtained  during  routine  knee  re- 
placements  from  the  Department  of  Orthopaedic  Surgery  and 
Trauma  at  the  Royal  Adelaide  Hospital.  Explants  of trabecular  bone 
were  cultured  as  described  previously?*  Cells  growing  out  of  the 
explants  display a characteristic  osteoblastic  phenotype  in  culture." 
Primary  human  bone  cells  were  used  as  a positive  control  for  osteo- 
calcin mRNA. 
Fluorescence-activated cell sorting (FACS).  This procedure  has 
been  reported  previously."  Briefly,  BMMNCs  (1 to 3  X  lo7  cells) 
were  pelleted  in 5 mL polypropylene  tubes  (Falcon;  Becton  Dickin- 
son, Linkon  Park,  NJ)  and  resuspended  in  200  pL of  saturating 
concentrations  of  the  mouse  IgM  MoAb  STRO-l for 45  minutes  at 
4°C  or  with  an  isotype-matched  MoAb  of  irrelevant  specificity, 
1A6.12  (donated by  Dr  L.K.  Ashman,  Department  of Hematology, 
IMVS, Adelaide,  Australia).  The  cells were  were  then  washed  twice 
in  HHF at 4"C, before  the  addition of 200 pL of  a 1150 dilution of 
phycoerythrin  (PE)-conjugated  goat  antimouse  IgM  p-chain-spe- 
cific  (Southern  Biotechnology  Associates,  Birmingham,  AL).  The 
cells  were  incubated  for  45  minutes  at  4°C  and  then  washed  twice 
in  HHF before  being  sorted  using  a FACSkfLus flow  cytometer 
(Becton  Dickinson,  Sunnyvale,  CA).  Cells  were  maintained  at 4°C 
throughout  the  cell  sorting  procedures.  STRO-l+ cells  were  defined 
as  those  exhibiting  a level  of  fluorescence  greater  than  99% of  that 
obtained  with  the  the  isotype-matched  control  antibody,  1A6.12. 
In vitro  formation of  bone mineral.  This  method  is a modifica- 
tion  of  two  different pr~ccedures,"~'~  adapted for human  BM  cells. 
STRO-l+ cells  (2  X  lo4/ T-25  culture  flask)  were  cultured  in  a 
modification  of  Eagle's medium  (a-MEM; Flow  Laboratories,  Ir- 
vine,  Scotland)  supplemented  with  20%  FCS,  L-glutamine (2 mmoY 
L), 0-mercaptoethanol (5  X  lo-'  mom) and  with  or without L- 
ascorbic  acid  2-phosphate  (100 pmovL, ASC-2P;  Novachem,  Mel- 
bourne,  Australia)  at  37°C  in  5% COz.  After  7 days, the  culture 
medium  was  switched  to  a"EM  supplemented  with 10% FCS, L- 
glutamine  (2  mmol/L),  dexamethasone  sodium  phosphate  (DEX; 
lo-'  mol&  David  Bull  Laboratories,  Sydney,  Australia),  ASC-2P 
(100 pmoVL), KH2P04  (1.8 mmoVL;  BDH  Chemicals,  Poole,  UK) 
to  give a final  phosphate  concentration  of  2.9  mmoVL,  and  HEPES 
(20 mmoVL)  for  those  cultures  initiated  with  ASC-2P.  Control  cul- 
tures  without  ASC-2P  were  maintained  in  a-MEM supplemented 
with  10%  FCS  and  L-glutamine  (2 mmoVL). The  media  was  changed 
twice a week for  varying  periods up to 6 weeks. 
Alkaline  phosphatase  acriviry.  Two-week-old  BM  cultures 
grown  under  osteogenic  inductive  conditions  (ascorbic  acid  2-phos- 
phate  [ASC-SP],  DEX,  and  inorganic  phosphate  [PO,i])  and  control 
cultures, were  incubated  with  either  a mouse  MoAb  specific  for 
human  liver  and  bone  alkaline  phosphatase,  B4-78  (Developmental 
Studies  Hybridoma  Bank,  University  of  Iowa,  Iowa  City,  IA),"  for 
45  minutes at 4°C.  Nonspecific  staining  was  assessed  by  incubating 
cells under  identical  conditions  with  an isotype-matched  MoAb  of 
irrelevant  specificity,  3D3  (generously  provided  by  Dr  L.K.  Ash- 
man). Cultures  were  then  washed  twice  in  RPM1  before  being  fixed 
in 2% paraformaldehyde for 20  minutes  at  4°C.  After  fixation,  a 
Vectastain  ABC  kit  for mouse IgG (PK-4010;  Vector  Laboratories, 
Burlingame,  CA)  and  a peroxidase  substrate  kit  AEC  (SK-4200; 
Vector  Laboratories) were  used  to  localize  specifically  bound  anti- 
body  according  to  the  manufacturer's  recommendations.  Alkaline 
phosphatase  activity  was  confirmed  by  histochemistry  performed  on 
replicate  cultures  using a Sigma  (St  Louis,  MO)  in  vitro  diagnostic 
kit,  85L-2,  according  to  the  manufacturer's  recommendations.  After 
immunostaining  and  histochemical  staining,  the  cells  were  counter 
stained  with  Mayer's  hematoxylin and examined  and  photographed 
using  an  Olympus  IMT-2  inverted light  microscope  (Olympus  Opti- 
cal, Ltd,  Tokyo,  Japan).  Photographs  were  taken  using  Kodak  Tech- 
nical  PAN  black  and  white  film  (Eastman  Kodak,  Rochester,  NY). 
Von Kossa staining of  bone-derived mineral.  Mineralized BM 
cultures  and  controls  were  gently  teased  off  as  single  layers  using 
a plastic  pipette.  The  cell  layers  were  fixed  in  95%  ethanol  for 
60 minutes  before  being  infiltrated  and  embedded  in  50%  glycol 
methacrylate  (Tokyo  Kasei,  Tokyo,  Japan)  and  50%  methyl  methac- 
rylate  (BDH  Chemicals)  over  1 week  at  room  temperature.  Trans- 
verse  sections  (5 pm) of  the  cell  layers  were  cut  using  a glass  knife  on 
a Jung K motorized  sledge  microtome  (Reichert-Jung,  Heidelburg, 
Germany).  Von  Kossa  staining  was  performed  according  to  the 
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Fig 1.  lmmunoperoxidase  staining  with  the  MoAb 84-78 depicting 
alkaline  phosphatase  activity  on BM  CFU-F cultured  for  2 weeks in 
the presence of  either FCS alone (A) or ASC-2P. DEX, and PO,!  (B). 
The  cultures  were  counter-stained  with  haematoxylin.  Cultures 
treated  with FCS alone  showed a heterogeneous  staining  pattern  of 
alkaline  phoshatase  activity.  A proportion of  cells  (25%)  in each col- 
ony  were  found  to express  alkaline  phosphatase  (arrow;  original 
magnification x2001 (A). In  the cultures  treated  with  ASC-2P. DEX, 
and PO,,,  greater  than  90% of  the cells in  each  colony  were  found 
to express  alkaline  phosphatase  (original  magnification  x200)  (B). 
Alkaline phosphatase  activity  could  not  be detected  when  the  same 
cells  were  incubated in the  presence of  the negative  control MoAb, 
3D3 (original  magnification x2001 (C). 
method  of  Pearse."  Sections  were  washed  twice in  distilled  water 
and then stained in  5% aqueous  AgN03  (May  & Baker  Laboratory 
Products,  West  Footscray.  Victoria,  Australia)  for 60  minutes  under 
UV  light.  After  staining  with  AgN03.  the  sections  were  placed  in 
5%  sodium  thiosulphate  (BDH  Chemicals)  for  1  minute.  The  sec- 
tions  were  counterstained  with  Mayer's  hematoxylin  and  eosin  and 
mounted in Uvinert  aqueous  mountant  (BDH  Chemicals).  Von Kossa 
staining  was  analyzed  using  an  Olympus  SZ-PT light microscope. 
Photographs  were  taken  using  Kodak  Technical  PAN  black  and 
white film. 
Detection  qf  osteocalcin  by  radioimmrrnonssay  (RIA).  This 
method is a modification  of that described by Lajeunesse  et a13'  and 
was  adapted  for  serum-deprived  conditions.  Six-week-old  mineral- 
ized  BM  cultures  and  controls  were  washed  twice  in  phosphate- 
buffered  saline  (PBS)  and then switched to serum-deprived  medium 
as previously described."  supplemented with CaCI2-2Hz0  (2  mmoll 
L; Sigma). KHIP04  (I  .8 mmolL).  menadione  sodium bisulfite (IO-' 
molL; vitamin  K?; Sigma),  and  calcitriol  (IO"  mol&  1,25-dihy- 
droxyvitamin  D,:  donated  by  F.  Hoffmann-La  Roche  Ltd.  Basel, 
Switzerland)  for 48 hours  at  37°C in 5%- CO?.  After  incubation,  the 
media  was  removed  and  the  osteocalcin  concentration  in the  medium 
was  measured  by  a specific  RIA  (Department  of  Endocrinology  of 
the  IMVS,  Adelaide,  South  Australia)  using  an  antibody  raised 
against  bovine  osteocalcin  (>90% homologous to human  osteocal- 
cin). In preliminary  experiments,  media  supplemented  with 1 % FCS 
contained  approximately  3 ng of  osteocalcin  per  milliliter, in contrast 
to serum-deprived  media,  which  contained  less  than  the  detection 
limit of  the  assay  of  0.4  ng of  osteocalcin  per  milliliter.  Background 
levels  of  osteocalcin  detected  in serum-deprived  media  alone  were 
compared  with  the  osteocalcin  levels  detected  in  the  cultures  (t- 
test).  The  results  were  expressed as the  mean  values  from  duplicate 
cultures  of  nanograms  of  osteocalcin  per  10'  cells  per  48 hours  of 
induction  with  I ,25-dihydroxyvitamin D,. 
Detection qfosteocalcin  mRNA by  Northern blot unnlysis.  Total 
RNA  from  the  same  BM cultures used  for RIA and  from  primary 
human  bone  cultures  was  extracted  by  the  acid  guanidinium-phenol- 
chloroform  method  as described  previously.2x  Denatured total RNA 
(20 pg)  was  separated  by  1 %-  agarose gel electrophoresis  and trans- 
ferred to a nylon  membrane  (Shleicher  & Schuell, Dassel, Germany). 
After UV cross-linking  and  prehybridization,  the blots were hybrid- 
ized  in  50% formamide  to  a  synthetic  oligonucleotide  probe  for 
human  osteocalcin  (S-CCACTCGTCACAGTCCGGATTGAG- 
CTCACACACCTCCCT-3'),  complementary  to  the  mRNA  se- 
quence  coding  for  amino  acids  20-32  of  mature  osteocalcin"'  at 42°C 
for 16 hours. The  probe  was  end-labeled  with (y-"P)-ATP  (Bresatec, 
Adelaide,  Australia).  Washes  were  performed  in  2x sodium  saline 
citrate  (SSC)  at  room  temperature,  followed  by  washings  at  42°C 
for  I  hour.  The  membrane  was  exposed  to  Kodak  X-Omat  film at 
-70°C  for  72  hours  with  a  Cronex  intensifying  screen  (du  Pont, 
Wilington, DE). The  integrity  of  the  RNA  analyzed  was  confirmed 
by  ethidium  bromide  staining. 
Transmission electron microscopy (TEM).  Six-week-old miner- 
alized  BM  cultures  were  washed  in 0.05 molL sodium  cacodylate 
buffer  and  then  fixed  in  2.5%  glutaraldehyde  (EM  grade)  in 0.05 
molL sodium  cacodylate  buffer  for  2  hours  at  room  temperature. 
After  washing  with 0.05 molL cacodylate  buffer,  the  cultures  were 
postfixed with  2%  osmium  tetroxide  (VIII;  BDH Chemicals) in caco- 
dylate  buffer  for  I  hour at  room  temperature  and  then  washed in 
cacodylate buffer. After  this procedure. the  cultures  were  dehydrated 
with  graded  alcohol  (70%.  9096, and  100%  ethanol  solutions)  for 
two  IS-minute  changes  for  each  alcohol  grade.  Epoxy  resin (TAAB 
Laboratories,  Berkshire,  UK)  was then used to infiltrate the  cultures 
overnight  at  37°C.  Polymerization  of  the  resin  was  performed  at 
60°C  for  24  hours  under  vacuum.  Ultrathin  sections  were  cut  on  a 
LKB 8800 Ultrotome I1 (Bromma,  Sweden)  and  mounted  on  copper 
grids.  Sections  were  then  examined  using  a  JEOL  1200  EX  11 
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Fig  2.  The mineral formed by 
human BM CFU-F cultured for  4 
weeks in  the presence  of ASC-PP, 
DEX, and PO,,  was shown to  be 
Von Kossa positive (original mag 
nification x 1001 (Al. Cultures  were 
counter-stained  with hematoxylin. 
A light microscopic  view of the ad- 
herent layers of  replicate cultures 
shows the development  of mineral 
deposits (large arrow) and the ap- 
pearance  of  clusters  of  adipocytes 
(small arrow) (original magnifica- 
tion x2001 (B). Deposits  of mineral 
were  never  observed  in the  BM 
CFU-F cultures grown in  the pres- 
ence  of  FCS  alone  (original  magni- 
fication x2001 (C). 
(Tokyo, Japan) transmission electron  microscope.  Photographs  were 
taken  using  ILFORD  EM Technical film (ILFORD Pty Ltd. Mobber- 
ley, UK).  Mineral deposits  were  analyzed  using  a Tracor-Northern 
Series  I1 EDX  System  (EDX:  Energy  Dispersive  x-ray  microana- 
lyzer).  Electron  diffraction  analysis  was  performed  using a camera 
length  of  100 cm on  the  mineralized  bone  cultures  and on a commer- 
cially  available  hydroxyapatite  standard  (hydroxyapatite  type  1: 
Sigma). 
RESULTS 
Induction  of  alkaline  phosphatase  expression  on  RM 
CFU-F.  STRO-I 
+
  and  STRO-I  ~  cells  derived  from 
BMMNCs  from  3  different  individuals  were  isolated  by 
FACS and cultured under standard CFU-F conditions, in the 
presence or absence of ASC-2P. All  cultures derived from 
STRO-I - cells failed to produce any CFU-F after 2 weeks 
in culture, in accord with previous observations,>' and  were 
therefore discarded.  In the STRO-I'  cultures, the CFU-F 
were allowed to develop for 7 days, at which  time  the  cul- 
tures were supplemented with  a combination of  ASC-2P, 
DEX.  and POJi  for those cultures initiated with  ASC-2P. The 
addition of  DEX  at  the  start of  culture caused a  marked 
decrease in the proliferation of  CFU-F that was evident by 
day 7 of culture. However, delayed addition of  DEX  did  not 
result in the inhibition of stromal cell proliferation (data not 
shown). For this reason, the addition of  DEX was therefore 
performed 7 days after culture initiation. 
BM  CFU-F colonies were analyzed for their expression 
of alkaline phosphatase, a well-documented marker of bone 
cell differentiation, by immunoperoxidase staining using the 
MoAb B4-78, which identifies the bone-  and  liver-specific 
form of the enzyme"  (Fig  I). Alkaline phosphatase activity 
was confirmed by  histochemistry performed on replicate cul- 
tures (data not  shown). After 2 weeks of  culture, all of the 
CFU-F colonies grown  in the presence of  ASC-2P,  DEX, 
and PO,,  were found  to  express alkaline phosphatase (Fig 
1 B).  Moreover,  within  individual  colonies.  consistently 
greater than 90% of the cells exhibited alkaline phosphatase. 
In contrast, the CFU-F cultured in the presence of FCS alone 
showed  a  heterogeneous  staining  pattern,  with  typically 
525% of  the cells  in each  colony showing positivity  for 
alkaline phosphatase (Fig  IA).  To  examine  which  factor 
was responsible for inducing alkaline phosphatase activity, 
STRO-  I 
+
 cells were  grown  in the presence of ASC-2P.  DEX, 
and PO.,,  and  in multiple combinations of  the three. DEX 
was  found  to  be  responsible for the  increased  expression 
of  alkaline phosphatase on  CFU-F colonies in all  groups 
examined when compared with CFU-F grown in FCS alone 
(data not shown). 
STRO-I'  BMMNCs  can  he  induced  to ,f.m  mineral. 
The adherent layers of  BM  cultures after 4 weeks in osteo- 
genic growth conditions (ASC-2P. DEX, and PO,)  displayed 
large areas of  mineralized  material  that  stained positively 
with  the  Von  Kossa technique (Fig 2A). Adipocytes  were 
also observed in the same cultures throughout  the  adherent 
layers, as seen by light  microscopy  under  phase  contrast  (Fig 
2B). Mineral deposits were  not  found  in the  control cultures 
with  FCS  alone (Fig 2C). 
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Fig 3.  Representative photographs  (dark field) of 
culture  flasks depicting  the confluent adherent  layers 
of BM  CFU-F cultured  for 6 weeks in the presence of 
ASC-2P.  DEX, or PO,,  (A) or cultured in the presence 
of  FCS  alone (B).  Descrete  areas of mineral deposits 
(arrow) were observed throughout the adherent  lay- 
,L"-"--  ~  __ -  "-.  .-__  *  ~  POli  (Al. No mineral  formation was observed  in  those 
ers of the cultures treated with ASCQP,  DEX,  and 
cultures treated with FCS alone (B). 
-  -.  -  - " ". ." 
"" 
A view of the  whole culture flasks  under dark field illumi- 
nation shows the extent of  mineralization after 6 weeks of 
induction with  ASC-2P.  DEX,  and  POli (Fig 3A). Transverse 
sections of  the  adherent  layers from  6-week-old cultures 
showed an  extensive multilayered growth pattern  that  was 
subsequently confirmed by  electron microscopic examina- 
tion  (see Fig  5 below).  A similar pattern  of  growth  was 
seen  in cultures grown  in FCS alone (Fig  4B).  However, 
mineralization was only evident  in cultures supplemented 
with ASC-2P, DEX, and POli, as shown by positive staining 
with the Von  Kossa reaction (Fig 4A). Human foreskin fi- 
broblasts cultured  under  identical conditions  for 6  weeks 
failed to produce a mineralized matrix (data not  shown). 
Ultrastructural  examination  of  the  cultures  by  TEM 
showed  that  the  mineral  was associated with collagen fibrils 
in the extracellular matrix  of  the adherent layers (Fig 5A 
and  B).  EDX  was  used  to  evaluate the nature of the mineral 
in these cultures. The calcium to phosphorus (Ca/P) ratio in 
the mineralized cultures was  1.76 5 0.10 (n = 3; Fig 5C), 
which  was  consistent with the Ca/P ratio of hydroxyapatite 
in vivo (1.67). X-ray diffraction studies also showed that the 
crystal structure of  the mineral deposits in the induced cul- 
tures (ASC-2P, DEX, and PO4,)  was identical to the crystal 
diffraction patterns obtained from the hydroxyapatite stan- 
dard (Fig 5D). 
To determine the  incidence of  CFU-F with  osteogenic 
potential, we  isolated  21 CFU-F clones by  limiting dilution 
in standard CFU-F growth conditions. Day-7 colonies were 
subsequently cultured for 4 weeks in the presence of  DEX, 
ASC-2P,  and  PO,.  After this procedure, the colonies were 
examined for the formation of  a mineralized  matrix.  All  of 
the 21 CFU-F clones cultured in the presence of  DEX,  ASC- 
2P,  and  PO4i were  shown to  be  positive for  Von  Kossa 
staining. In  addition, adipocytic formation was observed in 
only a proportion (48%) of the colonies examined (data not 
shown). 
Osteocalcin  production  by  BM  CFU-F.  Six-week-old 
mineralized BM  cultures and controls were washed in PBS 
and  then  placed  under  serum-deprived conditions. The bio- 
synthesis of  osteocalcin was stimulated for 48 hours by  the 
addition of  1,25-dihydroxyvitamin D3 (I ,25-Vit D3). Sam- 
ples were then  taken  from the medium of  all the cultures 
and analyzed for the presence of osteocalcin by  RIA.  Vary- 
ing levels of  osteocalcin (2.6 to  19.8  ng/lOh  ceIls/48 hours 
I .25-Vit D3 ) were detected in the  mineralized BM cultures, 
but  not  in control cultures grown  in the presence of  FCS 
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Fig 4.  Von Kossa staining of  transverse  sections 
of  the  adherent  layers from  cultured  BM CFU-F 
grown for 6 weeks in the presence  of  ASC-2P. DEX, 
and PO,i  (original magnification x2001 (A) or in the 
presence  of FCS alone (original  magnification x2001 
(B). The sections were counter-stained with hema- 
toxylin and eosin.  Areas  of Von Kossa-positive min- 
eral deposits (arrow)  were observed throughout the 
adherent layers  of the cultures  treated with ACS4P. 
DEX, and PO,, (A). No  Von Kossa-positive mineral 
could be detected in the adherent layers of the con- 
trol cultures treated with FCS alone (B). 
alone (Table l). In accord with this data, Northern blot analy- 
sis of  RNA  extracted from the mineralized BM stromal cell 
cultures and  from  primary  human  bone  cultures showed the 
presence of osteocalcin mRNA after stimulation of the cells 
for 48 hours of  incubation with  1,25-Vit  D,  (Fig 6). No 
osteocalcin mRNA was detected in the control BM cultures 
(FCS alone) stimulated with  1.25-Vit  D3. 
DISCUSSION 
Our data show that osteoprogenitors in human adult BM 
express the STRO-I  antigen. Although there is no single, 
definitive marker of cells of the osteogenic lineage, the cells 
produced under the culture conditions described in this report 
exhibit three widely accepted characteristics of  bone cells, 
ie,  high  expression of alkaline phosphatase?" production of 
a mineralized (hydroxyapatite) matrix, and  1,25-VitD3-de- 
pendent synthesis of the  bone  cell specific protein, osteocal- 
cin. The generation of osteoblast-like cells with these pheno- 
typic and functional characteristics was dependent on culture 
of the sorted STRO-I 
+
 precursor cells in the presence of  L- 
ascorbate, the glucocorticoid DEX, and a source of inorganic 
phosphate, in accord with other studies.'".'x 
Previous studies have determined that ascorbate is essen- 
tial for the survival of human osteoblasts in vitro.?' L-ascor- 
bate helps facilitate bone  cell  proliferation and differentiation 
by  increasing the total protein, collagen synthesis, and alka- 
line phosphatase  In  the  present  study, L-ascor- 
bate, which has a half-life of 7 hours in culture, was  replaced 
by  the  long-acting  derivative  of  L-ascorbate  (ASC-2P), 
which has a half-life of  7 days  in culture.*l Interestingly, 
alkaline phosphatase expression was not affected when  hu- 
man  BM CFU-F were  grown  in the presence of  ASC-2P 
when compared with the control cultures without  ASC-2P. 
The role of glucocorticoids in regulating osteogenic differ- 
entiation in vitro has not  been  precisely  defined.  A number of 
studies have shown that although DEX can  induce  terminal 
differentiation of  osteogenic cells in cultures, the presence 
of  this steroid is  not  an  absolute requirement for in vitro 
oste~genesis.".~~.~~  It  should be  noted  that  many  of  these 
reports are based  on  the use  of  rodent systems of  the  bone 
formation assay, the relevance of which as an in vitro  model 
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Fig 5.  TEM examination  of  the  adherent layers of 
BM  CFU-F cultured  for  6 weeks in the presence of 
ASC-2P. DEX, and PO,,  depicts  the  formation  of min- 
eral-like material  (hydroxyapatite  crystals; arrow) in 
the extracellular spaces of the adherent layers (origi- 
nal  magnification  x3.000) (A).  Examination  of theex- 
tracellular  matrix  showed  the  presence of deposits 
of hydroxyapatite-like crystals (large arrow) in asso- 
ciation  with a  network  of  collagen  fibrils  (small 
arrow)  (original  magnification  ~25,000) (B).  EDX 
analysis of similar  mineral  deposits, obtained  from 
three  different  BM  CFU-F cultures,  showed  major 
peaks for calcium (Ca) and phosphorous (P) (C), with 
a  mean  Ca/P ratio of  1.71 ? 0.1 (n = 31.  The x-ray 
diffraction  pattern  of  the  mineral  deposits, in the 
same cultures (Dl, was  found to  be  identical  to  that 
of the  hydroxyapatite  standard. 
of bone  cell  development has recently  been  questioned.33  In  increase the expression of  mRNA for many genes, including 
human studies, DEX has  been  shown  to  be  required for the  those encoding for alkaline phosphatase and various proto- 
differentiation of osteoblast-like cells present in BM stromal  oncogenes, such as  c-fos,"'  that are associated with  osteo- 
cultures.3" In vitro, DEX  was shown to inhibit the 1,25-Vit  genic differentiation.4050  In  the  present  study. the  addition 
D3-induced expression of osteocalcin in human BM  cells3"  of  DEX  to  the  culture medium increased the expression of 
and  human  bone  cells."  In contrast, DEX has been found to  alkaline phosphatase on CFU-F colonies. 
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Table 1.  Measurement of Osteocalcin Release 
in Human BM CFU-F Cultures 
Culture Conditions 
BM Sample  Control INS)  ASC-2P + DEX + PO,;' 
1  0.3  2 0.3  19.8  2 6.9 
2  0.2  2 0.2  9.7  2  1.8 
3  0.8  -r  0.6  2.6  2 1.1 
Values are the mean ? SE  nanograms of osteocalcin per 10'  cells 
per 48  hours of 1.25-Vit  D3  treatment. Adult  human  CFU-F cultured 
for 6 weeks in  the presence of either ASC-PP,  DEX,  and POIi  or in  the 
presence of FCS alone (control) were treated with 1.25-Vit  D3  for 48 
hours  in serum-deprived  conditions.  Samples of  the  supernatants 
from replicate cultures were analyzed for  the  presence of osteocalcin 
by RIA.  Osteocalcin levels in each sample were compared with  the 
background levels of osteocalcin detected in the serum-deprived me- 
dium alone.  Significant  levels of osteocalcin were only detected in 
those cultures treated with ASC-2P,  DEX,  and PO,,. 
Abbreviation: NS, not significant. 
P < .05 (t-test). 
Synthesis by  bone cells in vitro of  a mineralized matrix 
has previously been shown to be dependent on supplementa- 
tion  of  their  growth  medium  with  a  source of  inorganic 
phosphate."  In  this study, inorganic phosphate was used  in 
place of  &glycerophosphate,  which  is  a  nonphysiological 
organic phosphate substrate of  alkaline phosphatase.''  The 
presence of  0-glycerophoshate  in animal studies has  been 
shown to cause ectopic mineralization in cultures of fetal rat 
parietal cells and  skin  fibroblasts, which does not occur using 
inorganic phosphate.'."''  In  parallel studies, human foreskin 
fibroblasts cultured in the presence of  ASC-2P, DEX, and 
PO4, for a period of  6 weeks were  found  to be  Von  Kossa 
negative. 
Purified STRO-I 
+
  human BM cells were cultured under 
standard CFU-F growth conditions in the presence of ASC- 
2P. Day-7 CFU-F cultures were then switched to osteogenic 
inductive conditions  (ASC-2P,  PO4,, and  DEX).  After  2 
weeks, greater than 90% of  the cells in  all of  the CFU-F 
colonies were shown to express alkaline phoshatase. Previ- 
ous studies have shown that alkaline phosphatase is involved 
with the induction of hydroxyapatite deposition in collagen 
matrices in vivo."  The results of  the  present  study showed 
that the induction of  alkaline phosphatase expression pre- 
ceded the appearence of  Von  Kossa-positive mineral by  7 
to  14  days  in the  induced  cultures. TEM  analysis of  the 
adherent layers showed the presence of deposits of hydroxy- 
apatite-like crystals in association with the collagen fibrils 
in the  matrix.  EDX  analysis showed that the mineral was 
composed of  calcium (Ca) and phosphorus (P), consistent 
with  the  CdP ratio of  hydroxyapatite crystals in vivo."  In 
addition, the crystal structure of  the mineral was found to 
be  identical to  the crystal structure of  the  hydroxyapatite 
standard, as determined by  x-ray diffraction analysis. The 
presence of mineral deposits, which stained positive for the 
Von  Kossa  reaction, was shown in all CFU-F colonies iso- 
lated by  limiting dilution. This finding is in contrast to the 
findings in studies of  rodent BM that reported that  only  a 
proportion of CFU-F were capable of  developing an osteo- 
genic phenotype.4"'x  This discrepancy may be attributed to 
4171 
the presence of  accessory cells in the  relatively  crude BM 
preparations used  in these studies,"x.sx  which  may affect the 
expression of  the osteogenic phenotype of CFU-F in vitro. 
In addition, the  absence of  DEXJX  and  ascorbate5x  in the 
culture medium  may  lead  to an underestimation of the inci- 
dence of osteogenic precursors in rodent BM. 
Osteocalcin  is  an  osteoblast-specific proteins0 and  was 
therefore used in this study as a marker of osteogenic differ- 
entiation.  Cultured  primary  human  bone  cells  have  been 
shown to synthesize osteocalcin in the presence of  1,25-Vit 
D  32.fln.hl  In the present study, comparable levels of osteocal- 
cin were found in the culture medium of human BM cultures 
induced for 6 weeks under osteogenic conditions (ASC-2P, 
DEX,  and PO,,) and stimulated with  1 ,2S-VitD1  for 48 hours. 
The 1,25-VitD3-stimulated induction of osteocalcin mRNA 
was  confirmed  by  Northern  bot  analysis. 
This work provides direct evidence that  purified  human 
BM CFU-F  under  defined  in vitro culture conditions are 
capable of  osteogenic differentiation. These  findings also 
indicate  that  the  osteogenic  precursors  are  found  in  the 
STRO-1'  population of  human  BM. However,  this  study 
does not exclude the possibility of the presence of primitive 
osteogenic precursors in the STRO-I- fraction of  the BM. 
A 
B 
Fig 6. 
-  28s 
-  18s 
4- 0.6 kb 
1  2  34 
- 28s 
- 18s 
kL:.  .*L.IP  .L. 
A representative  autoradiograph  of  a formaldehyde-aga- 
rose gel electrophoresis of RNA from  human  BM  CFU-F cultured  for 
6 weeks in the presence of either ASC-LP,  DEX,  and POu (lane 1) or 
FCS alone (lane 2) and stimulated with Vi  D3  for 48 hours; primary 
human bone cells cultured  for 6 weeks in the presence of ASC-2P. 
with  Vit  D3  induction  for  48 hours (lane 3) or  without  Vit  D1 induction 
(lane 4). Descrete bands,  characteristic of osteocalcin mRNA were 
observed in lanes 1 and 3, after  hybridization with a specific '*P- 
labeled oligo-nucleotide  probe  (A). The integrity of the RNA analyzed 
was  confirmed  by  ethidium  bromide  staining  (B). 
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In our study, CFU-F could not be grown from the STRO- 
1  - fraction of  BM.  Previous studies have shown that  the 
STRO-l'  population contains cells with the potential to de- 
velop into a number of  distinct stromal cell types, including 
fibroblasts, smooth muscle cells, and adip~cytes.~'  The pres- 
ent work therefore extends the range of cell types into which 
STRO- 1 
+
 can develop. At a clonal level, approximately 50% 
of  the CFU-F examined showed the capacity to differentiate 
along both  the osteogenic and adipocytic cell lineages. It 
will be of  interest to determine whether, in adult BM, all 
four stromal elements arise from a common multipotential 
stromal precursor population as previously reported by  oth- 
er~.~~*~~  The answer to this question must await the develop- 
ment of techniques to genetically mark putative stromal stem 
cells and to follow their progeny. 
In conclusion, this study shows that osteoprogenitors in 
human BM are restricted to a  subpopulation of  cells that 
express  the  STRO-1  antigen. These  data provide  an  im- 
portant basis from which to attempt further enrichment and 
characterization of osteoprogenitor cells, in particular to in- 
vestigate more stringently their requirements for growth and 
differentiation and to identify culture conditions that  lead  to 
the expansion of  their number in vitro, with  a  view  toward 
potential clinical application of these cells. 
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